Advancing Global Health Equity: Investing in Integrated HIV, HPV, and Cervical Cancer Initiatives

May 30, 2024 @ 9:30 am ET - 11:00 am

amfAR, Funders Concerned About AIDS (FCAA), and Funders For Reproductive Equity (FRE) brought donors together to explore the pivotal role philanthropy can play in advancing integrated solutions for HIV, HPV, and cervical cancer.

In terms of global disease burden and impacted communities, HIV and cervical cancer intersect in a number of ways. According to AVAC and TogetHER:

The majority of women who die from cervical cancer live in low- and middle-income countries.
Women testing positive for the human papillomavirus (HPV) that causes cervical cancer are twice as likely to be infected with HIV.
Women living with HIV are six times more likely to develop invasive cervical cancer than their HIV-negative peers.
The proportion of cervical cancer cases attributable to HIV is greater than 40% among the eight countries with highest HIV prevalence in sub-Saharan Africa, compared to less than 5% in 127 countries with lower HIV prevalence.

Yet, despite commendable efforts from leading organizations such as the Global Fund, PEPFAR, and Unitaid, critical gaps persist in delivering HPV vaccination as well as cervical cancer screening and treatment programs to the communities most in need, highlighting the imperative for increased donor support and strategic integration.

This webinar brought together experts from the Biden Cancer Moonshot, Unitaid, the Elizabeth Glaser Pediatric AIDS Foundation, AVAC and more, to provide a multi-sector perspective on what this work looks like, and what the opportunities are for philanthropy.

Key questions that will guide our conversation include:

What are the implications of service integration on programs, policy, and research?
How do we center racial and gender justice in this work?
What are future directions philanthropy can take to address this critical need?